TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.…
What TriplePoint Venture Growth BDC (TPVG) Said on Its Q3 Earnings Call
TriplePoint Venture Growth BDC (NYSE: TPVG) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Asset Management industry, part of the Financial Services sector.
The shares were at 3.420 USD on 20 November 2026, down 38.0% over 52 weeks. Its 52-week range is 3.410 USD to 6.950 USD, and it trades at the bottom of that range.
At a market capitalisation of 139.68M USD, it trades at 6.0 times trailing earnings and 4.2 times forward earnings. The median trailing P/E of its 18 largest Asset Management peers is 14.8, a discount of 60% for TPVG.
TriplePoint Venture Growth BDC reports return on equity of 13.9%, an operating margin of 74.1% and revenue down 10.8% year over year.
Its debt exceeds its cash by 381.74M USD, a debt-to-equity ratio of 1.33. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 5.667 USD is 65.7% above the current price. The next earnings report is expected on 3 March 2027.